| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Leap Chem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (852) 3060-6658 | |||
![]() |
market19@leapchem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink standard supplier since 2015 | ||||
| Nanjing Sunsure Chemical Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (25) 5853-5435 | |||
![]() |
sales@sunsurechem.com | |||
| Chemical manufacturer since 2018 | ||||
| chemBlink standard supplier since 2018 | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (831) 457-3800 | |||
![]() |
scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Archimica Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (302) 994-3043 | |||
![]() |
contact@archimica.com | |||
| Chemical manufacturer since 1946 | ||||
| Toronto Research Chemicals Inc. | Canada | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (416) 665-9696 | |||
![]() |
info@trc-canada.com | |||
| Chemical manufacturer since 1982 | ||||
| VDM Biochemicals | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (330) 252-8181 | |||
![]() |
sales@vdmbio.com info@vdmbio.com | |||
| Chemical manufacturer | ||||
| Euticals S.p.A. | Italy | Inquire | ||
|---|---|---|---|---|
![]() |
+39 (371) 490-2339 | |||
![]() |
contact@archimica.com | |||
| Chemical manufacturer since 1946 | ||||
| Classification | API >> Nervous system medication >> Anti-shock palsy |
|---|---|
| Name | Bromocriptine mesylate |
| Synonyms | 2-Bromo-alpha-ergocryptine methanesulfonate; (+)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6'-18-trione methanesulfonate salt |
| Molecular Structure | ![]() |
| Molecular Formula | C32H40BrN5O5.CH4SO3 |
| Molecular Weight | 750.70 |
| CAS Registry Number | 22260-51-1 |
| EC Number | 244-881-1 |
| Safety Description | S22;S24/25 Details | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Classification | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Bromocriptine mesylate |